Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Method of inhibiting alveolar bone resorption and periodontal membrane loss and composition for internal use to be used therein

a technology of alveolar bone resorption and periodontal membrane loss, which is applied in the direction of biocide, plant/algae/fungi/lichens ingredients, drug compositions, etc., can solve the problems of low degree of inhibition, and low degree of safety, so as to inhibit alveolar bone resorption and periodontal. , the effect of reducing bone density

Inactive Publication Date: 2007-10-04
SUNSTAR INC
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Benefits of technology

The present invention provides a method, oral composition, and prevention or treatment agent for inhibiting alveolar bone resorption, periodontal membrane loss, and gingival recession in individuals with decreased bone density, postmenopausal women, or periodontal disease patients in a maintenance phase. The invention uses a combination of a soy isoflavone aglycone, calcium, and vitamin D3. The oral composition contains a soy isoflavone aglycone, calcium, and vitamin D3 in a specific ratio to achieve the desired effect. The invention also provides a method for inhibiting alveolar bone resorption, periodontal membrane loss, and gingival recession by orally administering the composition for an extended period of time. The invention is safe and effective even when taken for extended periods of time.

Problems solved by technology

Decreased bone density is caused by aging, nutrition / diet problems such as shortage of calcium intake, lack of exercise, medicines such as adrenal corticosteroids, etc.
In particular, women tend to suffer a rapid decrease of bone mass because of decreased estrogen secretion due to menopause.
However, since bisphosphonate has strong side effects, it is not suitable for periodontal disease treatment, which requires long-term medication.
Because inflamed parts and affected tissues are physically removed in the process of treatment, the treated area tends to suffer gingival recession.
Like ordinary calcium supplements, these are in oral tablet, capsule, and powder forms and are not intended for the prevention of periodontal disease.
However, the above periodontal disease prevention is based on the antibacterial properties of soy isoflavones, and there has been no reported case of inhibited periodontal membrane loss.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method of inhibiting alveolar bone resorption and periodontal membrane loss and composition for internal use to be used therein
  • Method of inhibiting alveolar bone resorption and periodontal membrane loss and composition for internal use to be used therein

Examples

Experimental program
Comparison scheme
Effect test

example 1

Granule (Ingestion: 4 g per day)

[0059] Granules were produced by a standard method, using the following components:

ComponentAmount (%)Whey calcium50.00(calcium content: 26%)Soy isoflavone extract1.00(aglycon content: 30%)(genistein: daidzein = 1.5:1)Oil-soluble licorice extract1.00Vitamin D3 (vitamin D3 content: 0.25%)0.05Xylitol40.00PalatinitBalanceAspartame0.10Gum arabic1.00Flavor2.50Total100.00

example 2

Intraoral Solution Tablet (Ingestion: 4 g per day)

[0060] Intraoral solution tablets were produced by a standard method, using the following components:

ComponentAmount (%)Oyster shell calcium35.00(calcium content: 39%)Soy isoflavone extract0.5(aglycon content: 70%)(genistein: daidzein = 1.3:1)PalatinitBalanceMaltitol30.00Vitamin D3 (vitamin D3 content: 0.25%)0.05Polydextrose5.00Sucrose fatty acid ester4.00Cocoa powder5.00Sucralose1.00Flavor2.50Total100.00

example 3

Intraoral Solution Tablet (Ingestion: 4 g per day)

[0061] Intraoral solution tablets were produced by a standard method, using the following components:

ComponentAmount (%)Calcium tertiary phosphate35.00(calcium content: 39.1%)Soy isoflavone extract1.50(aglycon content: 33%)(genistein: daidzein = 1.3:1)Vitamin K0.01Vitamin D3 preparation0.1(vitamin D3 content: 0.25%)Xylitol31.00PalatinitBalanceCitric acid0.50Gum Arabic1.20Magnesium stearate1.00Flavor3.00Total100.00

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
particle diameteraaaaaaaaaa
thicknessaaaaaaaaaa
diameteraaaaaaaaaa
Login to View More

Abstract

Alveolar bone resorption, periodontal membrane loss, and gingival recession can be inhibited by administering 500 mg to 2000 mg per day of calcium, 10 mg to 40 mg per day of soy isoflavone aglycone, and vitamin D3 to persons having a tendency for decreased bone density, postmenopausal women, and periodontal disease patients in a maintenance phase; and even an extended period of administration provides a high degree of safety.

Description

TECHNICAL FIELD [0001] The present invention relates to a method for inhibiting alveolar bone resorption and periodontal membrane loss of persons having a tendency for decreased bone density, postmenopausal women, and periodontal disease patients in a maintenance phase; a method for inhibiting gingival recession of such persons; and an oral composition, an agent for preventing or treating gingival recession, and an agent for preventing or treating alveolar bone resorption and periodontal membrane loss, each comprising a soy isoflavone aglycone, calcium, and vitamin D3. BACKGROUND ART [0002] Decreased bone density is caused by aging, nutrition / diet problems such as shortage of calcium intake, lack of exercise, medicines such as adrenal corticosteroids, etc. In particular, women tend to suffer a rapid decrease of bone mass because of decreased estrogen secretion due to menopause. Here, a person having decreased bone density is one whose bone mineral density is 1 SD (Standard Deviation...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(United States)
IPC IPC(8): A61K33/06A61K31/59A61K31/353A61K31/352A61K31/593A61K36/48
CPCA61K31/352A61K31/593A61K33/06A61K36/48A61K2300/00A61P1/02A61P19/00
Inventor SEKIMOTO, YUKIYOOTSUKI, HIDEHIKOTAKEMURA, AKANE
Owner SUNSTAR INC
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com